Surgical site infections (SSI) are one of the leading causes of clinical and economic burden for healthcare systems worldwide. According to a 2013 meta-analysis, SSI are the third most costly type of healthcare-acquired infections (HAI), with an estimated cost of US $20,785 per patient case. The annual costs of SSI in Europe are estimated to range between €1.47 and €19.1 billion, with a median additional length of stay in the hospital of 10 days.
LR SSI Factsheet Finanz 201208 EN - (320 KB)
